FOXN3 Knockout HEPG2 Cell Line

The choice depends on whether you are studying FOXN3 (forkhead box N3, CHES1)'s role as a checkpoint suppressor or its emerging functions in glucose metabolism and hepatic biology. The Knockout line is the standard tool for asking whether FOXN3 is required for these processes — FOXN3 is a forkhead transcription factor originally identified as a checkpoint suppressor in S. cerevisiae complementation; FOXN3 has emerged as a regulator of hepatic glucose production with FOXN3 polymorphisms associated with fasting glucose in human GWAS. Overexpression is useful for studying FOXN3 in heterologous expression contexts. For hepatic metabolism research, the EDITGENE FOXN3 Knockout in Hep-G2 is highly relevant — Hep-G2 is a hepatocellular carcinoma cell line and FOXN3 has been characterized as a regulator of hepatic glucose production. This product complements the parallel FOXN3 Knockout in A-549 (also available) for hepatic versus lung cancer cross-validation. Rescue with wild-type FOXN3 is the standard specificity control. The knockout is valuable for studying FOXN3-dependent hepatic gene regulation, fasting glucose biology, and emerging FOXN3-related metabolic disease research.

Primary applications: • Hepatic gene regulation: RNA-seq analysis of FOXN3-dependent transcriptional changes in hepatocellular context. • Glucose production: gluconeogenesis assays (G6Pase, PEPCK activity) given FOXN3's role in hepatic glucose production. • Checkpoint suppression: cell cycle and DNA damage response analysis given FOXN3's historical role as a checkpoint suppressor. • Cross-background comparison: parallel analysis with FOXN3 Knockout in A-549 (also available) for hepatic versus lung cancer cross-validation. EDITGENE recommends this Hep-G2-based model for hepatic FOXN3 research and metabolic disease studies.

Yes. FOXN3 rescue experiments require attention to forkhead transcription factor architecture: • Construct design: use a codon-modified FOXN3 sequence with a small C-terminal tag (FLAG, HA). FOXN3 has central forkhead DNA-binding domain and N/C-terminal regulatory regions — preserve all elements. • DNA-binding-deficient rescue: forkhead domain mutations abolish DNA binding and serve as the standard specificity control. • Functional readout: rescue should restore FOXN3-dependent transcriptional programs in hepatocellular context. Hep-G2-specific considerations: • Hep-G2 is a human hepatocellular carcinoma cell line widely used for hepatocyte differentiation, drug metabolism, and liver biology research. • Lentiviral transduction is supported with moderate efficiency. • Hep-G2 retains many hepatocyte features (albumin synthesis, CYP450 expression, transferrin synthesis) and serves as a complementary HCC model to Huh-7.